Analysis of CMV-specific T-cell reconstitution following BMT to identify patients risk of late onset CMV disease

被引：0
|
作者：
Hebart, H
Krause, H
Wagner, I
Muller, CA
Jahn, G
Einsele, H
机构：
[1] MED KLIN & POLIKLIN,TUBINGEN,GERMANY
[2] INST KLIN & EPIDEMIOL VIRUSKRANKHEITEN,TUBINGEN,GERMANY
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：852 / 852
页数：1
相关论文
共 50 条
  • [41] TCR repertoire evolution during maintenance of CMV-specific T-cell populations
    Schober, Kilian
    Buchholz, Veit R.
    Busch, Dirk H.
    IMMUNOLOGICAL REVIEWS, 2018, 283 (01) : 113 - 128
  • [42] Rapid reconstitution of CMV-specific T-cells after stem-cell transplantation
    Widmann, Thomas
    Sester, Urban
    Schmidt, Tina
    Gaertner, Barbara C.
    Schubert, Joerg
    Pfreundschuh, Michael
    Sester, Martina
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (01) : 38 - 47
  • [43] CMV-Specific T Cell Responses Predict the Risk of CMV Viremia After Discontinuation of Prophylaxis in SOT.
    Camargo, J.
    Resende, M.
    Zamel, R.
    Huibner, S.
    Klement, W.
    Kumar, D.
    Humar, A.
    Jurisica, I.
    Kaul, R.
    Keshavjee, S.
    Husain, S.
    TRANSPLANTATION, 2014, 98 : 269 - 269
  • [44] CMV-specific donor T cells for the treatment of recurrent CMV infections in transplanted patients
    Tonn, T.
    Grigoleit, G. U.
    Busch, D.
    Germeroth, L.
    Schuly, N.
    Anderl, F.
    Odendahl, M.
    Seifried, E.
    Einsele, H.
    VOX SANGUINIS, 2008, 95 : 203 - 203
  • [45] Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab
    R Lamba
    G Carrum
    G D Myers
    C M Bollard
    R A Krance
    H E Heslop
    M K Brenner
    U Popat
    Bone Marrow Transplantation, 2005, 36 : 797 - 802
  • [46] Clinical Implications of the CMV-Specific T-Cell Response and Local or Systemic CMV Viral Replication in Patients With Moderate to Severe Ulcerative Colitis
    Jung, Kyung Hwa
    Kim, Jihun
    Lee, Ho-Su
    Choi, Jene
    Jang, Se Jin
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Lee, Sang-Oh
    Choi, Sang-Ho
    Kim, Yang Soo
    Woo, Jun Hee
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Ye, Byong Duk
    Yang, Suk-Kyun
    Kim, Sung-Han
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (12):
  • [47] Memory T-cells of CMV-negative donors are superior recipients of CMV-specific T-cell receptor RNA
    Thomas, S.
    Klobuch, S.
    Plachter, B.
    Heemskerk, M.
    Theobald, M.
    Herr, W.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S313 - S314
  • [48] Reconstitution of CMV-specific CD8+T-cells following allogeneic stem cell transplantation (SCT):: Evaluation of tetramers for prediction of recurrent CMV reactivation
    Gratama, JW
    Brooimans, RA
    Löwenberg, B
    Sullivan, LA
    Gasior, GH
    Boyce, CS
    Southwick, PC
    Cornelissen, JJ
    HUMAN IMMUNOLOGY, 2004, 65 : S60 - S60
  • [49] Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy
    Kampouri, Eleftheria
    Ibrahimi, Sarah S.
    Xie, Hu
    Wong, Elizabeth R.
    Hecht, Jessica B.
    Sekhon, Mandeep K.
    Vo, Alythia
    Stevens-Ayers, Terry L.
    Green, Damian J.
    Gauthier, Jordan
    Maloney, David G.
    Perez, Ailyn
    Jerome, Keith R.
    Leisenring, Wendy M.
    Boeckh, Michael J.
    Hill, Joshua A.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (04) : 1022 - 1032
  • [50] Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with alemtuzumab
    Lamba, R
    Carrum, G
    Myers, GD
    Bollard, CM
    Krance, RA
    Heslop, HE
    Brenner, MK
    Popat, U
    BONE MARROW TRANSPLANTATION, 2005, 36 (09) : 797 - 802
12345